Preclinical investigation of tissue barrier function with HP-129Xe MRI

MRC · United Kingdom government procurement

This opportunity is now closed. GlobalGov surfaces government procurement from around the world, including the markets your competitors overlook.

Closed
Status

Opportunity Overview

Hyperpolarised 129-xenon (HP-129Xe) gas MRI of the lung produces distinct spectral signals from airspace, blood-air barrier and capillary red blood cell compartments. This established non-invasive clinical imaging technique provides a unique potential mechanism for determining the efficiency of molecular diffusion across the blood-air barrier via a range of biomarkers. Despite the potential importance of these biomarkers in diagnosing and monitoring important lung diseases associated with high morbidity and mortality, including chronic obstructive pulmonary disease (COPD), idiopathic pulmonary fibrosis (IPF), cystic fibrosis (CF), asthma and post-COVID-19 interstitial lung disease, this approach suffers from a lack of biological validation, leaving their interpretation insecure. The studentship will address this need by preclinical application of HP-129Xe MRI in small animal models of fibrotic and inflammatory
lung disease to assess blood-air barrier function and response to pharmacological intervention. Results will be validated against conventional lung imaging modalities such as CT, PET or SPECT, and related to established measures of lung structure (tissue sample histology) and function (pulmonary function tests (PFTs)). Investigations of tissue barrier function with HP-129Xe MRI may extend beyond the lungs to the intestines and brain.
Objectives
All objectives are expected to result in peer reviewed publications for the prospective student:
Develop methods for quantitative assessment of blood-air barrier structure & function using HP-
129Xe MRI in small animal models of pulmonary fibrosis (e.g. bleomycin) and inflammation (e.g.
elastase or LPS instillation)
Make new mechanistic discoveries by relating HP-129Xe MRI measurements to disease
pathogenesis and progression, and by observing response to pharmacological intervention. For example, selective modulation of molecular targets of interest, such as TRPV4 (Transient receptor potential cation channel subfamily...

Your competitors are watching the same crowded contracts everyone else is. Track live opportunities like this one worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.

Start Free

Solicitation Details

Issuing agencyMRC
CountryUnited Kingdom
CategoryResearch & Development
PublishedSeptember 30, 2023
Procurement stageActive solicitation
ClosedClosing date not published
StatusClosed — no longer accepting responses
Official sourceView original notice
Last verifiedOctober 11, 2026

Source: UK Research and Innovation (UKRI) — Open Government Licence v3.0.

Browse Similar Open Opportunities in United Kingdom

University Interactions - NDA Research Portfolio
University Interactions - NDA Research Portfolio - Single Supplier Framework
Disposal System Science & Technology Framework
MOPAC: Research Services: Public Attitude Survey, User Satisfaction Survey & Telephone & Digital Investigation Unit
UKHSA Knowledge, Attitudes and Behavioural Research Preliminary Market Engagement Notice
Highland Deephaven: Strategic Masterplanning & Feasibility Study
Digital Transformation and Research & Innovation Consultancy Open Framework
Gambling Research Services

See every United Kingdom Research & Development opportunity your competition is missing. Free for 14 days.

Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required

See who is already competing here →

Get a free United Kingdom Research & Development intelligence report in your inbox

A personalized report on United Kingdom Research & Development opportunities, emailed in 5-10 minutes. One per month, no account needed.